IMMUNIC, INC. — Director's Dealing 2023

Jun 29, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2023-06-28

Reporting Person: Rudick Richard Alan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-28	Stock Option	$1.94	A	16000	Acquired	2033-06-28	Common Stock (16000)	Direct

Footnotes

F1: The option vests in monthly increments over a period of one year from the grant date.